GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » General and Admin. Expense

SomnoMed (ASX:SOM) General and Admin. Expense : A$17.22 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is SomnoMed General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. SomnoMed's General and Admin. Expense for the six months ended in Dec. 2023 was A$15.98 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$17.22 Mil.

SomnoMed General and Admin. Expense Historical Data

The historical data trend for SomnoMed's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed General and Admin. Expense Chart

SomnoMed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.22 10.46 11.21 13.81 14.15

SomnoMed Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.18 1.64 12.91 1.24 15.98

SomnoMed General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$17.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SomnoMed General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of SomnoMed's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed (ASX:SOM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » General and Admin. Expense
Comparable Companies
ASX:EYE ASX:CVB ASX:NTI ASX:MX1 ASX:CMP ASX:IMR ASX:UBI ASX:RSH ASX:CSX ASX:LBT ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH
Traded in Other Exchanges
SOMNF:USA RJV:Germany
Address
20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
Website
https://www.somnomed.com/au
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (ASX:SOM) Headlines

No Headlines